Surya A Reis Selected Research

Surya A Reis Research Topics

3	Frontotemporal Dementia (Semantic Dementia) 01/2024 - 07/2017
2	Tauopathies 01/2021 - 01/2019
2	Neoplasms (Cancer) 01/2020 - 01/2019
2	Intellectual Disability (Idiocy) 01/2020 - 01/2011
2	Autism Spectrum Disorder 01/2020 - 01/2011
2	Cognitive Dysfunction 02/2016 - 01/2013
1	Epilepsy (Aura) 01/2020
1	Tuberous Sclerosis (Bourneville's Disease) 01/2020
1	Neurodevelopmental Disorders 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 11/2019
1	Atrophy 01/2019
1	Mental Disorders (Mental Disorder) 01/2018
1	AIDS-Related Complex (ARC) 11/2017
1	Central Nervous System Diseases (CNS Diseases) 02/2016
1	Huntington Disease (Huntington's Disease) 06/2011
1	Ischemia 06/2011
1	Carcinoma (Carcinomatosis) 10/2010
1	Fragile X Syndrome (Martin Bell Syndrome) 05/2004

2	ProgranulinsIBA 01/2024 - 07/2017
2	Proteins (Proteins, Gene)FDA Link 11/2017 - 05/2004
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2017 - 01/2013
2	Histone Deacetylase InhibitorsIBA 07/2017 - 01/2013
2	ChromatinIBA 02/2016 - 01/2013
2	Fragile X Mental Retardation ProteinIBA 01/2011 - 05/2004
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	tau Proteins (tau Protein)IBA 01/2021
1	trans-sodium crocetinate (crocetin)IBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	Glycogen Synthase Kinase 3IBA 11/2019
1	Farnesyltranstransferase (Farnesyltransferase)IBA 01/2019
1	lonafarnib (SCH 66336)IBA 01/2019
1	AnkyrinsIBA 01/2018
1	Lysine (L-Lysine)FDA Link 11/2017
1	(7- (2- ((1,1'- biphenyl)- 4- ylmethylene)hydrazinyl)- N- hydroxy- 7- oxoheptanamide)IBA 01/2013
1	GranulinsIBA 01/2013
1	Cadherins (E-Cadherin)IBA 06/2011
1	polyglutamineIBA 06/2011
1	Adenosine Triphosphate (ATP)IBA 06/2011
1	Adenosine Diphosphate (ADP)IBA 06/2011
1	5' Untranslated Regions (5' UTR)IBA 01/2011
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2010
1	Hydroxamic Acids (Hydroxamic Acid)IBA 10/2010
1	Protein Isoforms (Isoforms)IBA 10/2010
1	Carboxylic AcidsIBA 10/2010

5	Therapeutics 01/2021 - 05/2004